Amparo Güemes

Amparo Güemes

Auto-generated profile, based on publicly available information

Amparo Güemes

Department of Engineering, Electrical Engineering Division, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2018 in Bioelectronic Medicine
Verified
Journal Article
Open access
PDF file
AGAmparo Güemes
Amparo Güemes
PGPantelis Georgiou
Pantelis Georgiou
Diabetes is a disease caused by a breakdown in the glucose metabolic process resulting in abnormal blood glucose fluctuations. Traditionally, control has involved external insulin injection in response to elevated blood glucose to substitute the role of the beta cells in the pancreas which would otherwise perform this function in a healthy individual. The central nervous system (CNS), however, also plays a vital role in glucose homoeostasis through the control of pancreatic secretion and insulin sensitivity which could potentially be used as a pathway for enhancing glucose control. In this review, we present an overview of the brain regions, peripheral nerves and molecular mechanisms by which the CNS regulates glucose metabolism and the potential benefits of modulating them for diabetes management. Development of technologies to interface to the nervous system will soon become a reality through bioelectronic medicine and we present the emerging opportunities for the treatment of type 1 and type 2 diabetes.

13 September 2019 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Open access
AGAmparo Guemes
Amparo Guemes
Giacomo CapponGiacomo Cappon
Giacomo Cappon
BHBernard Hernandez
Bernard Hernandez
MRMonika Reddy
Monika Reddy
NONicholas Oliver
Nicholas Oliver
PHPau Herrero
Pau Herrero
In type 1 diabetes management, maintaining nocturnal blood glucose within target range can be challenging. Although semi-automatic systems to modulate insulin pump delivery, such as low-glucose insulin suspension and the artificial pancreas, are starting to become a reality, their elevated cost and performance below user expectations is hindering their adoption. Hence, a decision support system that helps people with type 1 diabetes, on multiple daily injections or insulin pump therapy, to avoid undesirable overnight blood glucose fluctuations (hyper- or hypoglycaemic) is an attractive alternative. In this paper, we introduce a novel data-driven approach to predict the quality of overnight glycaemic control in people with type 1 diabetes by analyzing commonly gathered data during the day-time period (continuous glucose monitoring data, meal intake and insulin boluses). The proposed approach is able to predict whether overnight blood glucose concentrations are going to remain within or outside the target range, and therefore allows the user to take the appropriate preventive action (snack or change in basal insulin). For this purpose, a number of popular established machine learning algorithms for classification were evaluated and compared on a publicly available clinical dataset (i.e. OhioT1DM). Although there is no clearly superior classification algorithm, this study indicates that, by using commonly gathered data in type 1 diabetes management, it is possible to predict the quality of overnight glycaemic control with reasonable accuracy (AUC-ROC= 0.7).

30 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAlejandro Carnicer-Lombarte
Alejandro Carnicer-Lombarte
ABAlexander J. Boys
Alexander J. Boys
AGAmparo Güemes
Amparo Güemes
JGJohannes Gurke
Johannes Gurke
SVSantiago Velasco-Bosom
Santiago Velasco-Bosom
GMGeorge Malliaras
George Malliaras
Implantable devices interfacing with peripheral nerves exhibit limited longevity and resolution. Poor nerve-electrode interface quality, invasive surgical placement and development of foreign body reaction combine to limit research and clinical application of these devices. Here, we develop cuff implants with a conformable design that achieve high-quality and stable interfacing with nerves in chronic implantation scenarios. When implanted in sensorimotor nerves of the arm in awake rats for 21 days, the devices record nerve action potentials with fascicle-specific resolution and extract from these the conduction velocity and direction of propagation. The cuffs exhibit high biocompatibility, producing lower levels of fibrotic scarring than clinically equivalent PDMS silicone cuffs. In addition to recording nerve activity, the devices are able to modulate nerve activity at sub-nerve resolution to produce a wide range of paw movements. When used in a partial nerve ligation rodent model, the cuffs identify and characterise changes in nerve C fibre activity associated with the development of neuropathic pain in freely-moving animals. The developed implantable devices represent a platform enabling new forms of fine nerve signal sensing and modulation, with applications in physiology research and closed-loop therapeutics.

1 August 2023 in Journal of Neural Engineering
Verified
Journal Article
Open access
KAKhaled Aboumerhi
Khaled Aboumerhi
AGAmparo Güemes
Amparo Güemes
HLHongtao Liu
Hongtao Liu
FTFrancesco Tenore
Francesco Tenore
RERalph Etienne-Cummings
Ralph Etienne-Cummings
In recent years, there has been a growing demand for miniaturization, low power consumption, quick treatments, and non-invasive clinical strategies in the healthcare industry. To meet these demands, healthcare professionals are seeking new technological paradigms that can improve diagnostic accuracy while ensuring patient compliance. Neuromorphic engineering, which uses neural models in hardware and software to replicate brain-like behaviors, can help usher in a new era of medicine by delivering low power, low latency, small footprint, and high bandwidth solutions. This paper provides an overview of recent neuromorphic advancements in medicine, including medical imaging and cancer diagnosis, processing of biosignals for diagnosis, and biomedical interfaces, such as motor, cognitive, and perception prostheses. For each section, we provide examples of how brain-inspired models can successfully compete with conventional artificial intelligence algorithms, demonstrating the potential of neuromorphic engineering to meet demands and improve patient outcomes. Lastly, we discuss current struggles in fitting neuromorphic hardware with non-neuromorphic technologies and propose potential solutions for future bottlenecks in hardware compatibility.

10 May 2024 in Science Advances
Verified
Journal Article
Open access
BWBen J. Woodington
Ben J. Woodington
JLJiang Lei
Jiang Lei
ACAlejandro Carnicer-Lombarte
Alejandro Carnicer-Lombarte
AGAmparo Güemes-González
Amparo Güemes-González
TNTobias E. Naegele
Tobias E. Naegele
DBDamiano Giuseppe Barone
Damiano Giuseppe Barone
The spinal cord is crucial for transmitting motor and sensory information between the brain and peripheral systems. Spinal cord injuries can lead to severe consequences, including paralysis and autonomic dysfunction. We introduce thin-film, flexible electronics for circumferential interfacing with the spinal cord. This method enables simultaneous recording and stimulation of dorsal, lateral, and ventral tracts with a single device. Our findings include successful motor and sensory signal capture and elicitation in anesthetized rats, a proof-of-concept closed-loop system for bridging complete spinal cord injuries, and device safety verification in freely moving rodents. Moreover, we demonstrate potential for human application through a cadaver model. This method sees a clear route to the clinic by using materials and surgical practices that mitigate risk during implantation and preserve cord integrity.

21 December 2022 in Advanced Materials
Verified
Journal Article
Open access
ABAlexander J. Boys
Alexander J. Boys
ACAlejandro Carnicer‐Lombarte
Alejandro Carnicer‐Lombarte
AGAmparo Güemes‐Gonzalez
Amparo Güemes‐Gonzalez
DNDouglas C. van Niekerk
Douglas C. van Niekerk
SHSam Hilton
Sam Hilton
GMGeorge Malliaras
George Malliaras
Bioelectronics hold the key for understanding and treating disease. However, achieving stable, long‐term interfaces between electronics and the body remains a challenge. Implantation of a bioelectronic device typically initiates a foreign body response, which can limit long‐term recording and stimulation efficacy. Techniques from regenerative medicine have shown a high propensity for promoting integration of implants with surrounding tissue, but these implants lack the capabilities for the sophisticated recording and actuation afforded by electronics. Combining these two fields can achieve the best of both worlds. Here, the construction of a hybrid implant system for creating long‐term interfaces with tissue is shown. Implants are created by combining a microelectrode array with a bioresorbable and remodellable gel. These implants are shown to produce a minimal foreign body response when placed into musculature, allowing one to record long‐term electromyographic signals with high spatial resolution. This device platform drives the possibility for a new generation of implantable electronics for long‐term interfacing.